MTEX Mannatech Inc.

Mannatech Unveils Advanced K-Beauty Skincare Line, Luminovation

Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today revealed its new skincare line, Luminovation™, exclusively for its Korean market at its annual Asia Mannatech Vision Program event in Seoul.

Mannatech’s Luminovation skincare line will be available for pre-order in the Korea market in July.

The Luminovation skincare line includes eight innovative new products suitable for all skin types and priced for the mass market. The product line includes a Multi Action Cleansing Balm, Ultra Mild Cleansing Gel, Pure Nature Balancing Toner, Hydra Micro Capsule Serum, Active Hydrating Lotion, Hydra Force Moisturizing Cream, Pure Mild Sun Protector and Miracle Sleeping Mask, all of which are designed to help prevent the signs of aging.

“The Luminovation skincare line is part of the K-beauty wave of advanced beauty and skincare products that are in great demand,” said Mannatech’s CEO and President, Alfredo “Al” Bala. “Mannatech has once again delivered a science-backed, natural solution; this time for improving the health and wellness of the body’s largest organ – the skin. These eight products feature some of the best of ingredients and exclusive technology that you won’t see in any other skincare line.”

Several of Mannatech’s Luminovation products have a pH of 5.5, the skin’s optimal pH, which may keep the skin from fluctuating from oily to dry for a balanced, flawless appearance. These product formulas are mild and not only remove impurities from the skin but also keep it hydrated appropriately. The Luminovation line also includes Mannatech’s exclusive Glyconutrients for improved skin health and wellness.

“We believe we are leading innovation for skincare, and our Associates are very excited to experience what these advanced products can deliver,” said Mannatech’s President of Asia, Patrick Park. “As the skincare innovation capital of the world, we are proud to introduce the Luminovation line that we believe will transform the way our customers view skincare and view themselves as they embrace our natural, effective solutions.”

The Luminovation skincare line is set apart from other skincare brands with four distinct characteristics. Luminovation products are made with mild, plant-based ingredients and with high technology, science-backed formulas that are exclusive to Mannatech. Thirdly, unlike the majority of skincare products, Luminovation includes Glyconutrients, which are exclusive ingredients derived from nature that nourish the skin to look and feel its best. Finally, Mannatech is widely recognized for innovation and high quality, which will ensure that Luminovation will deliver customers one of the best skin solutions available in the market today.

To begin changing your life and the lives of those around you, please visit Mannatech.com.

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience that makes a difference in the lives of people across the world. Through its innovative Glyconutrition products, Mannatech changes lives, providing an unprecedented level of natural wellness, freedom and purpose. With more than 20 years of experience and operations in 26 markets^, Mannatech is committed to changing lives. For more information, visit Mannatech.com.

Read more about Mannatech’s forward-looking statements.

^Mannatech operates in China under a cross-border e-commerce platform that is separate from its multi-level marketing model.

EN
07/07/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mannatech Inc.

 PRESS RELEASE

Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of ...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that on November 20, 2024, the Board of Directors of Mannatech, Incorporated (the “Board”) appointed Robert A. Toth to the Board where he will serve as Vice Chairman of the Board of Mannatech, Incorporated (the "Company") effective December 1, 2024. Mr. Toth will serve as a Class III director of the Board. Mr. Toth previously served on the Company's Board between March 2008 through May 31, 2023. Mr. Toth previously served as the Chairman of the Compensation and Stock Option Plan Committee, served on the Audit Committee, the Nominat...

 PRESS RELEASE

Mannatech Reports Financial Results for Third Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024. Third Quarter Highlights Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $0.4 million, or 1.2%, and unfavorable foreign exchange caused a $0.5 million decrease...

 PRESS RELEASE

Mannatech Reports Financial Results for Second Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024. Second Quarter Highlights Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.2 million, or 12.9%, and unfavorable foreign exchange caused a $0.7 million decrease ...

 PRESS RELEASE

Mannatech Announces Appointment of James Clavijo as Chief Financial Of...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical c...

 PRESS RELEASE

Mannatech Reports Financial Results for First Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2024. First Quarter Highlights Net sales for the quarter ended March 31, 2024 were $29.4 million, as compared to $34.1 million for the same period in 2023, a decrease of $4.7 million, or 13.8%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $3.9 million, or 11.3%, and unfavorable foreign exchange caused a $0.8 million decrease in GAAP net sales as compar...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch